AZN

#5321
AstraZeneca PLC - American Depositary Shares
185.7 1 USD
-0.15%
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
184.74
185.75
Range Annuel
68.62
212.71
Changement quotidien
-0.15%
Changement Mensuel
-1.47%
Evolution sur 6 mois
+99.80%
Changement Annuel
+161.27%
Clôture Précédente
185.9 8
Open
184.8 6
Low
184.7 4
High
185.7 5
Volume
822
Afficher le graphique complet Full chart

Financials

Aperçu Relevé Statistiques Dividendes
Trimestriel Annuel
Compte de résultat Bilan Flux de trésorerie
Valeur Q4, 24Q4, 25 TTM

AstraZeneca PLC - American Depositary Shares

AstraZeneca plc is a Swedish–British multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, UK. It has a portfolio of products for major diseases in areas including oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory, and inflammation. The company was founded in 1999 through the merger of the Swedish Astra AB and the British Zeneca Group. Zeneca shareholders received 53.5% of the shares, while Astra shareholders received the remaining 46.5%. Its portfolio includes primary and speciality care, coverage for rare diseases, and a robust global presence across various regions. Since the merger it has been among the world's largest pharmaceutical companies and has made numerous corporate acquisitions, including Cambridge Antibody Technology, MedImmune, Spirogen and Definiens. It has its research and development concentrated in three strategic centres: Cambridge, UK; Gothenburg, Sweden; and Gaithersburg, Maryland, US. AstraZeneca traces its earliest corporate history to 1913, when Astra AB was formed by a large group of doctors and apothecaries in Södertälje.

Nouvelles